Comments

Novavax Stock Price, Quotes and Forecasts

Q: What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NVAXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$6.24

0.6411.43%

At close: -

$6.29

0.050.80%

After Hours: 6:40 PM EDT

Novavax (NVAX) Forecast

News Earnings Novavax (NVAX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Novavax Stock Price, Quotes and Forecasts | NASDAQ:NVAX | Benzinga

Explore Novavax stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NVAX.

Open	$5.40
Close	$6.24
Volume / Avg.	9.21M / 4.45M
Day Range	$5.33 - $6.32
52 Wk Range	3.81 - 23.86
Market Cap	$1.01B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	29
Short Interest	29.09%
Days to Cover	9.5

Recent News

Despite Headwinds, Biotech Sell-Off Could Offer Buying Opportunity: Analyst

Biotech stocks face a tough 2025 with SMid-cap losses up to 40% YTD. BofA cites FDA changes, tariffs, and capital struggles but notes potential opportunities.

Vandana Singh

FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED)

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.

Vandana Singh

Moderna, Novavax Shares Are Tumbling Monday: What's Going On?

Vaccine stocks are trading lower Monday following a shakeup at the U.S. Food and Drug Administration.

Adam Eckert

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$5.40
Close	$6.24
Volume / Avg.	9.21M / 4.45M
Day Range	$5.33 - $6.32
52 Wk Range	3.81 - 23.86
Market Cap	$1.01B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	29
Short Interest	29.09%
Days to Cover	9.5

About Novavax, Inc.

Sector

Health Care

Industry

Biotechnology

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical sta...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Novavax (NVAX) stock?

You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.

View our list of the best stock brokerages

Who are Novavax (NVAX) competitors?

Other companies in Novavax’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Syndax Pharmaceuticals (NASDAQ:SNDX) and Day One Biopharmaceutical (NASDAQ:DAWN).

What is the forecast, or price target, for Novavax (NVAX) stock?

Novavax has a consensus price target of $48.13.

What is the current price for Novavax (NVAX)?

The stock price for Novavax (NASDAQ: NVAX) is $6.29 last updated April 4, 2025 at 6:40 PM EDT.

Does Novavax (NVAX) pay a dividend?

There are no upcoming dividends for Novavax.

When is Novavax (NASDAQ:NVAX) reporting earnings?

Novavax’s Q1 earnings are confirmed for Friday, May 9, 2025.

Is Novavax (NVAX) going to split?

There is no upcoming split for Novavax.

What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.